Liver Cirrhosis. K74.6
Conditions
Sponsors
Tehran University of Medical Sciences
Eligibility
Sex/Gender
All
Age
30 Years to 60 Years
Inclusion criteria
Inclusion criteria: Liver cirrhosis diagnosed by a Doctor for at least 6 months Age range from 30 to 60 years Willingness to participate in the study
Exclusion criteria
Exclusion criteria: End-stage Liver Disease Model Score greater than 18 or class 3 Child score Active gastrointestinal bleeding Serum Creatinine greater than 1.5 mg/dL during the past month Alcohol and Tobacco consumption during the last 6 months; Pregnancy and Breastfeeding Suffering from Diabetes, Pulmonary, Psychological, Hepatocellular Carcinoma and other Cancers, Heart Failure, Acute Viral Hepatitis, Cholestatic Cirrhosis, Autoimmune Cirrhosis, other Autoimmune Diseases. Hyperuricemia and Musculoskeletal Diseases Taking Corticosteroid and Immunosuppressive Drugs
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Weight. Timepoint: Before intervention and 12 weeks after the intervention. Method of measurement: Digital scale.;Height. Timepoint: Before intervention and 12 weeks after the intervention. Method of measurement: Stadiometer.;Body Mass Index (BMI). Timepoint: Before intervention and 12 weeks after the intervention. Method of measurement: Body weight (kilogram) divided by the square of height (meter).;Hepatic Encephalopathy Score. Timepoint: Before intervention and 12 weeks after the intervention. Method of measurement: Psychometric Hepatic Encephalopathy Score Test.;Quality Of Life Score. Timepoint: Before intervention and 12 weeks after the intervention. Method of measurement: Questionnaire measuring Quality Of Life in Chronic Liver Disease. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSomayyeh Asghari
Tehran University of Medical Sciences
Outcome results
None listed